Shimizu J - Search Results

1

Gefitinib for the treatment of non-small-cell lung cancer.

Hida T, Ogawa S, Park JC, Park JY, Shimizu J, Horio Y, Yoshida K. Hida T, et al. Among authors: shimizu j. Expert Rev Anticancer Ther. 2009 Jan;9(1):17-35. doi: 10.1586/14737140.9.1.17. Expert Rev Anticancer Ther. 2009. PMID: 19105704 Review.

2

[Molecular targeted therapy--non-small-cell lung cancer and gefitinib].

Shimizu J, Horio Y, Mitsudomi T. Shimizu J, et al. Gan To Kagaku Ryoho. 2005 Nov;32(12):1879-85. Gan To Kagaku Ryoho. 2005. PMID: 16282720 Review. Japanese.

3

Prospective validation for prediction of gefitinib sensitivity by epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer.

Yoshida K, Yatabe Y, Park JY, Shimizu J, Horio Y, Matsuo K, Kosaka T, Mitsudomi T, Hida T. Yoshida K, et al. Among authors: shimizu j. J Thorac Oncol. 2007 Jan;2(1):22-8. J Thorac Oncol. 2007. PMID: 17410005 Free article. Clinical Trial.

4

mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines.

Shimizu J, Horio Y, Osada H, Hida T, Hasegawa Y, Shimokata K, Takahashi T, Sekido Y, Yatabe Y. Shimizu J, et al. Respirology. 2008 Jun;13(4):510-7. doi: 10.1111/j.1440-1843.2008.01302.x. Respirology. 2008. PMID: 18494946

5

Epidermal growth factor receptor mutations in small cell lung cancer.

Tatematsu A, Shimizu J, Murakami Y, Horio Y, Nakamura S, Hida T, Mitsudomi T, Yatabe Y. Tatematsu A, et al. Among authors: shimizu j. Clin Cancer Res. 2008 Oct 1;14(19):6092-6. doi: 10.1158/1078-0432.CCR-08-0332. Clin Cancer Res. 2008. PMID: 18829487

6

Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib.

Katayama T, Shimizu J, Suda K, Onozato R, Fukui T, Ito S, Hatooka S, Sueda T, Hida T, Yatabe Y, Mitsudomi T. Katayama T, et al. Among authors: shimizu j. J Thorac Oncol. 2009 Nov;4(11):1415-9. doi: 10.1097/JTO.0b013e3181b62572. J Thorac Oncol. 2009. PMID: 19692934 Free article.

7

Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations.

Yoshida K, Yatabe Y, Park J, Ogawa S, Park JY, Shimizu J, Horio Y, Matsuo K, Mitsudomi T, Hida T. Yoshida K, et al. Among authors: shimizu j. J Cancer Res Clin Oncol. 2010 Apr;136(4):527-35. doi: 10.1007/s00432-009-0685-2. Epub 2009 Sep 24. J Cancer Res Clin Oncol. 2010. PMID: 19777258

8

Relationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell lines.

Horio Y, Osada H, Shimizu J, Ogawa S, Hida T, Sekido Y. Horio Y, et al. Among authors: shimizu j. Cancer Chemother Pharmacol. 2010 Jul;66(2):237-43. doi: 10.1007/s00280-009-1151-1. Epub 2009 Oct 7. Cancer Chemother Pharmacol. 2010. PMID: 19809814

9

The safety and tolerability of intravenous ASA404 when administered in combination with docetaxel (60 or 75 mg/m²) in Japanese patients with advanced or recurrent solid tumors.

Daga H, Hida T, Ishikawa S, Shimizu J, Tokunaga S, Horio Y, Kobayashi K, Takeda K. Daga H, et al. Among authors: shimizu j. Jpn J Clin Oncol. 2011 Sep;41(9):1067-73. doi: 10.1093/jjco/hyr110. Epub 2011 Aug 10. Jpn J Clin Oncol. 2011. PMID: 21835825 Clinical Trial.

10

Crizotinib-induced esophageal ulceration: a novel adverse event of crizotinib.

Park J, Yoshida K, Kondo C, Shimizu J, Horio Y, Hijioka S, Hida T. Park J, et al. Among authors: shimizu j. Lung Cancer. 2013 Sep;81(3):495-496. doi: 10.1016/j.lungcan.2013.06.017. Epub 2013 Jul 25. Lung Cancer. 2013. PMID: 23891512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,055 results

Search Page

Filters